BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33765721)

  • 1. [Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
    Han S; Meng F; Zhang HK; Li HL; Qu JR
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):798-802. PubMed ID: 33765721
    [No Abstract]   [Full Text] [Related]  

  • 2. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
    Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative identification of cytokeratin 19 status of hepatocellular carcinoma based on diffusion kurtosis imaging.
    Chen J; Liu D; Guo Y; Zhang Y; Guo Y; Jiang M; Dai Y; Yao X
    Abdom Radiol (NY); 2023 Feb; 48(2):579-589. PubMed ID: 36416905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
    Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
    Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
    Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
    PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma.
    Huang Z; Xu X; Meng X; Hou Z; Liu F; Hua Q; Liu Q; Xiu J
    Eur J Radiol; 2015 Dec; 84(12):2464-9. PubMed ID: 26456310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
    World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
    Li X; Zhang K; Shi Y; Wang F; Meng X
    J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34, PCNA and CK19 expressions in AFP- hepatocellular carcinoma.
    Cui DJ; Wu Y; Wen DH
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5200-5205. PubMed ID: 30178842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
    Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
    Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application value of prognosis of nutrition index and apparent diffusion coefficient in patient with hepatocellular carcinoma underwent transarterial chemoembolization].
    Sun WH; Zhang AD; Li W
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(33):2581-2585. PubMed ID: 31510716
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma.
    Nakanishi M; Chuma M; Hige S; Omatsu T; Yokoo H; Nakanishi K; Kamiyama T; Kubota K; Haga H; Matsuno Y; Onodera Y; Kato M; Asaka M
    Ann Surg Oncol; 2012 Apr; 19(4):1302-9. PubMed ID: 21927976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.
    Wang HQ; Yang C; Zeng MS; Rao SX; Ji Y; Weng X; Wang JY; Sheng RF
    Eur J Radiol; 2019 Aug; 117():164-170. PubMed ID: 31307643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
    Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
    Zhang X; Wu Z; Peng Y; Li D; Jiang Y; Pan F; Li Y; Lai Y; Cui Z; Zhang K
    Biomed Res Int; 2021; 2021():6651397. PubMed ID: 33954191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
    Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
    Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.